Evidence map›Paper›PMID 39135908›Full record

ArticleThe Lancet regional health. Western Pacific2024

The cost-effectiveness of a co-managed care model for elderly hip fracture patients in China: a modelling study.

Lizheng Xu, Minghui Yang, Xinyi Zhang, Jing Zhang, Jiusheng He, Liangyuan Wen, Xianhai Wang, Zongxin Shi, Sanbao Hu, Fengpo Sun and 11 more

Abstract read
In one paragraph

Article in The Lancet regional health. Western Pacific, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Geriatric Models of Surgical Care: A Scoping Review.Journal of advanced nursing · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Lizheng XuThe George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
Minghui YangDepartment of Orthopaedics and Traumatology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Xinyi ZhangSchool of Public Health, Harbin Medical University, Harbin, China.
Jing ZhangSchool of Public Health, Harbin Medical University, Harbin, China.
Jiusheng HeDepartment of Orthopaedics, Beijing Shunyi District Hospital, Beijing, China.
Liangyuan WenDepartment of Orthopaedics, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Xianhai WangDepartment of Orthopaedics, Beijing Changping District Hospital, Beijing, China.
Zongxin ShiDepartment of Orthopaedics, Beijing Liangxiang Hospital, Beijing, China.
Sanbao HuDepartment of Orthopaedics, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Fengpo SunDepartment of Orthopaedics, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Zishun GongDepartment of Orthopaedics, Beijing Liangxiang Hospital, Beijing, China.
Mingyao SunDepartment of Orthopaedics, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ke PengNational Clinical Research Centre for Cardiovascular Diseases, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, China.
Pengpeng YeNational Centre for Non-Communicable Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China.
Ruofei MaDepartment of Orthopaedics and Traumatology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Xinbao WuDepartment of Orthopaedics and Traumatology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Mingsheng ChenSchool of Health Policy & Management, Nanjing Medical University, Nanjing, China.
Stephen JanThe George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
Rebecca IversThe George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
Maoyi TianSchool of Public Health, Harbin Medical University, Harbin, China.
Lei SiSchool of Health Sciences, Western Sydney University, Campbelltown, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The clinical effectiveness of multidisciplinary co-managed care for hip fracture patients in China has been demonstrated in a multicenter non-randomized controlled study. This study aims to estimate the cost-effectiveness of the co-managed care. Methods: The study is based on a multicenter clinical trial (n = 2071) in China. We developed a state transition microsimulation model to estimate the cost-effectiveness of the co-managed care compared with usual care for hip fracture patients from healthcare system perspective. The costs incorporated into the model included hospitalization costs, post-discharge expenses, and secondary fracture therapy costs. Effectiveness was measured using quality-adjusted life years (QALYs). Costs and effects were discounted at 5% annually. A simulation cycle length of 1-year and a lifetime horizon were employed. The cost-effectiveness threshold was established at USD 37,118. To address uncertainties, one-way deterministic sensitivity analysis and probabilistic sensitivity analysis were conducted. Findings: In the base case analysis, the co-managed care group had a lifetime cost of USD 31,571 and achieved an effectiveness of 3.22 QALYs, whereas the usual care group incurred a cost of USD 27,878 and gained 2.85 QALYs. The incremental cost-effectiveness ratio was USD 9981 per QALY gained; thus the co-managed care model was cost-effective. The cost-effectiveness was sensitive to the age of having hip fractures and hospitalization costs in the intervention group. Interpretation: The co-managed care in hip fracture patients represents value for money, and should be scaled up and prioritized for funding in China. Funding: The study is supported by Capital's Funds for Health Improvement and Research (2022-1-2071, 2018-1-2071).

Indexed as

ChinaCo-managed careCost-effectiveness analysisElderly populationHip fracture

Identifiers

PMID39135908
PMCPMC11318548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.